Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/24 17:42 | 9/4/24 | DYN | Health | Drug | Pharmaceutical Preparations | Cox John | MA | DO | CEO,P | P | 1,057 | 33.04 | 0 | 32 | 640 | 37 | I | ||||||||||||||
1/11/24 16:31 | 1/9/24 | DYN | Health | Drug | Pharmaceutical Preparations | Kersten Dirk | MA | DT | P | 30,000 | 17.50 | 0 | 1,714 | 1,429 | I | ||||||||||||||||
12/14/22 16:56 | 12/12/22 | DYN | Health | Drug | Pharmaceutical Preparations | Rhodes Jason P | MA | D | P | 10,000 | 10.70 | 0 | 935 | 10 | 9,869 | I | |||||||||||||||
12/14/22 16:55 | 12/12/22 | DYN | Health | Drug | Pharmaceutical Preparations | Atlas Venture Opportunity Fund Ii, L.P. | MA | T | P | 10,000 | 10.70 | 0 | 935 | 10 | 9,869 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |